ALLAN BUENAVENTURA: Open Payments
NPI 1649831223 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 25 payments from 8 companies in 2025. Trend: 2023 $324 · 2024 $780 · 2025 $1,937
Food & beverage: $1,937
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $560 |
| AstraZeneca Pharmaceuticals LP | 8 | $530 |
| Vanda Pharmaceuticals Inc. | 5 | $277 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Verona Pharma, Inc. | 1 | $118 |
| Inspire Medical Systems, Inc. | 1 | $118 |
| Pharming Healthcare, Inc. | 1 | $107 |
| Grifols USA, LLC | 1 | $102 |
Products named: AIRSUPRA, FANAPT, Ozempic, BREZTRI, Wegovy, ZENPEP, Ohtuvayre, INSPIRE.
Industry payments across AZ — which companies pay providers there.
